Lake Street Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-2,429
Closed -$240K – 272
2024
Q3
$240K Sell
2,429
-25
-1% -$2.46K 0.04% 228
2024
Q2
$228K Buy
2,454
+80
+3% +$7.17K 0.03% 292
2024
Q1
$225K Buy
2,374
+95
+4% +$8.81K 0.03% 290
2023
Q4
$203K Buy
+2,279
New +$169K 0.03% 292

Other funds holding XBI

Lake Street Private Wealth's XBI Position: Q4 2024 in Review

Lake Street Private Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 2,429 shares — an estimated $240K sold.

Lake Street Private Wealth first reported a position in XBI in Q4 2023 and held it in 4 quarters. The position peaked at $240K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Lake Street Private Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Lake Street Private Wealth sold 2,429 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $240K.
  • Lake Street Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 4 quarters.
  • Lake Street Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $240K in Q3 2024.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Lake Street Private Wealth's 13F filing for Q4 2024, filed 15 Jan 2025.